| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |